Meridian Investment Counsel’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $448K | Hold |
854
| – | – | 0.12% | 150 |
|
|
2025
Q1 | $542K | Hold |
854
| – | – | 0.16% | 134 |
|
|
2024
Q4 | $608K | Hold |
854
| – | – | 0.18% | 121 |
|
|
2024
Q3 | $898K | Hold |
854
| – | – | 0.27% | 96 |
|
|
2024
Q2 | $898K | Hold |
854
| – | – | 0.28% | 91 |
|
|
2024
Q1 | $822K | Sell |
854
-35
| -4% | -$33.7K | 0.27% | 92 |
|
|
2023
Q4 | $781K | Hold |
889
| – | – | 0.27% | 89 |
|
|
2023
Q3 | $732K | Buy |
889
+1
| +0.1% | +$823 | 0.27% | 91 |
|
|
2023
Q2 | $638K | Hold |
888
| – | – | 0.23% | 105 |
|
|
2023
Q1 | $730K | Hold |
888
| – | – | 0.28% | 93 |
|
|
2022
Q4 | $641K | Hold |
888
| – | – | 0.26% | 103 |
|
|
2022
Q3 | $612K | Hold |
888
| – | – | 0.27% | 98 |
|
|
2022
Q2 | $525K | Sell |
888
-70
| -7% | -$41.4K | 0.22% | 111 |
|
|
2022
Q1 | $669K | Hold |
958
| – | – | 0.23% | 109 |
|
|
2021
Q4 | $605K | Buy |
+958
| New | +$605K | 0.2% | 111 |
|